RE:RE:RE:New Presentation is up
“Currently dosing a number of additional patients at 420mg/m2”
So my guess they have stopped the single at a time patient dose escalation and moved to groups with the starting dose 420mg/m2.
Is the trial moving slowly? Not to me as it seems it’s on schedule based on what has been said since they started 10 months ago and each cycle can take 6 weeks they would have 6 or 7 cycles and that’s about it. And that’s not the end of the escalation if no DLT next stop is 560mg/m2 and so on. Of course a little bit more measured and clear communication would make it much easier for everyone to make their own educated guess.
I didn’t save the previous IP so the below could have been there but it does clearly say the NASH funding would be non-dilutive.
I personally feel better if it turns out to be true.
“In parallel, exploring other non-dilutive financing options to initiate trial prior to partnership finalization”